170 related articles for article (PubMed ID: 18608095)
21. Variability and prognostic relevance of different phenotypes in amyotrophic lateral sclerosis - data from a population-based registry.
Wolf J; Safer A; Wöhrle JC; Palm F; Nix WA; Maschke M; Grau AJ
J Neurol Sci; 2014 Oct; 345(1-2):164-7. PubMed ID: 25086855
[TBL] [Abstract][Full Text] [Related]
22. Amyotrophic lateral sclerosis: prognostic indicators of survival.
Mandrioli J; Faglioni P; Nichelli P; Sola P
Amyotroph Lateral Scler; 2006 Dec; 7(4):211-20. PubMed ID: 17127559
[TBL] [Abstract][Full Text] [Related]
23. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study.
Chiò A; Calvo A; Moglia C; Mazzini L; Mora G;
J Neurol Neurosurg Psychiatry; 2011 Jul; 82(7):740-6. PubMed ID: 21402743
[TBL] [Abstract][Full Text] [Related]
24. [Survival prediction and related risk factors of amyotrophic lateral sclerosis:analysis of 65 cases].
Qiao L; Zhang J; Fan DS
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(11):742-5. PubMed ID: 18683681
[TBL] [Abstract][Full Text] [Related]
25. Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis.
Turner MR; Bakker M; Sham P; Shaw CE; Leigh PN; Al-Chalabi A
Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Mar; 3(1):15-21. PubMed ID: 12061944
[TBL] [Abstract][Full Text] [Related]
26. A role for functional classification in the early identification of prognostic factors in ALS.
Rauchway AC; Kaiboriboon K; Bansal SK; Kulkantrakorn K; Guo X; Parks BJ; Hayat GR
Amyotroph Lateral Scler; 2007 Aug; 8(4):214-6. PubMed ID: 17653918
[TBL] [Abstract][Full Text] [Related]
27. A rating scale for amyotrophic lateral sclerosis: description and preliminary experience.
Appel V; Stewart SS; Smith G; Appel SH
Ann Neurol; 1987 Sep; 22(3):328-33. PubMed ID: 3118763
[TBL] [Abstract][Full Text] [Related]
28. Natural history of amyotrophic lateral sclerosis. Observations with the Charing Cross Amyotrophic Lateral Sclerosis Rating Scales.
Guiloff RJ; Goonetilleke A
Adv Neurol; 1995; 68():185-98. PubMed ID: 8787229
[TBL] [Abstract][Full Text] [Related]
29. Respiratory systems abnormalities and clinical milestones for patients with amyotrophic lateral sclerosis with emphasis upon survival.
Vender RL; Mauger D; Walsh S; Alam S; Simmons Z
Amyotroph Lateral Scler; 2007 Feb; 8(1):36-41. PubMed ID: 17364434
[TBL] [Abstract][Full Text] [Related]
30. Disease progression and survival in ALS: first multi-state model approach.
Gil J; Preux PM; Alioum A; Ketzoian C; Desport JC; Druet-Cabanac M; Couratier P
Amyotroph Lateral Scler; 2007 Aug; 8(4):224-9. PubMed ID: 17653920
[TBL] [Abstract][Full Text] [Related]
31. Longitudinal analysis of progression of dysphagia in amyotrophic lateral sclerosis.
Higo R; Tayama N; Nito T
Auris Nasus Larynx; 2004 Sep; 31(3):247-54. PubMed ID: 15364359
[TBL] [Abstract][Full Text] [Related]
32. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS.
Kimura F; Fujimura C; Ishida S; Nakajima H; Furutama D; Uehara H; Shinoda K; Sugino M; Hanafusa T
Neurology; 2006 Jan; 66(2):265-7. PubMed ID: 16434671
[TBL] [Abstract][Full Text] [Related]
33. Survival and clinical features in Hispanic amyotrophic lateral sclerosis patients.
Martínez HR; Molina-López JF; Cantú-Martínez L; González-Garza MT; Moreno-Cuevas JE; Couret-Alcaraz P; Treviño SA; Webb-Vargas Y; Caro E; Gil-Valadez A; Santos-Guzmán J; Hernandez-Torre M
Amyotroph Lateral Scler; 2011 May; 12(3):199-205. PubMed ID: 21344998
[TBL] [Abstract][Full Text] [Related]
34. Predictors of long survival in amyotrophic lateral sclerosis: a population-based study.
Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Samarelli V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G
J Neurol Sci; 2008 May; 268(1-2):28-32. PubMed ID: 18021808
[TBL] [Abstract][Full Text] [Related]
35. Predictability of disease progression in amyotrophic lateral sclerosis.
Czaplinski A; Yen AA; Simpson EP; Appel SH
Muscle Nerve; 2006 Dec; 34(6):702-8. PubMed ID: 16967489
[TBL] [Abstract][Full Text] [Related]
36. A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS.
Jawaid A; Murthy SB; Wilson AM; Qureshi SU; Amro MJ; Wheaton M; Simpson E; Harati Y; Strutt AM; York MK; Schulz PE
Amyotroph Lateral Scler; 2010 Dec; 11(6):542-8. PubMed ID: 20500116
[TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics and survival pattern of 1,153 patients with amyotrophic lateral sclerosis: experience over 30 years from India.
Nalini A; Thennarasu K; Gourie-Devi M; Shenoy S; Kulshreshtha D
J Neurol Sci; 2008 Sep; 272(1-2):60-70. PubMed ID: 18550082
[TBL] [Abstract][Full Text] [Related]
38. Ciliary neurotrophic factor genotype does not influence clinical phenotype in amyotrophic lateral sclerosis.
Al-Chalabi A; Scheffler MD; Smith BN; Parton MJ; Cudkowicz ME; Andersen PM; Hayden DL; Hansen VK; Turner MR; Shaw CE; Leigh PN; Brown RH
Ann Neurol; 2003 Jul; 54(1):130-4. PubMed ID: 12838531
[TBL] [Abstract][Full Text] [Related]
39. Assessment of pulmonary function in amyotrophic lateral sclerosis.
Talakad N S; Pradhan C; Nalini A; Thennarasu K; Raju TR
Indian J Chest Dis Allied Sci; 2009; 51(2):87-91. PubMed ID: 19445444
[TBL] [Abstract][Full Text] [Related]
40. Influence of statins treatment on survival in patients with amyotrophic lateral sclerosis.
Drory VE; Bronipolsky T; Artamonov I; Nefussy B
J Neurol Sci; 2008 Oct; 273(1-2):81-3. PubMed ID: 18678378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
